Shuo Ma

8.8k total citations · 2 hit papers
160 papers, 3.2k citations indexed

About

Shuo Ma is a scholar working on Genetics, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Shuo Ma has authored 160 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Genetics, 60 papers in Pathology and Forensic Medicine and 43 papers in Molecular Biology. Recurrent topics in Shuo Ma's work include Chronic Lymphocytic Leukemia Research (80 papers), Lymphoma Diagnosis and Treatment (53 papers) and Viral-associated cancers and disorders (15 papers). Shuo Ma is often cited by papers focused on Chronic Lymphocytic Leukemia Research (80 papers), Lymphoma Diagnosis and Treatment (53 papers) and Viral-associated cancers and disorders (15 papers). Shuo Ma collaborates with scholars based in United States, China and Australia. Shuo Ma's co-authors include Rex L. Chisholm, Charles A. Parkos, Sunil K. Shaw, Francis W. Luscinskas, Asma Nusrat, Qijun Qian, Xinyue Wang, Steven T. Rosen, Zhong Li and Changzheng Zhang and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Shuo Ma

147 papers receiving 3.2k citations

Hit Papers

Current Progress in CAR-T Cell Therapy for Solid Tumors 2019 2026 2021 2023 2019 2023 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Current Progress in CAR-T Cell Therapy for Solid Tumors
    2019 358 citations Shuo Ma, Xinchun Li et al. profile →
  2. Clinical application and detection techniques of liquid biopsy in gastric cancer
    2023 120 citations Shuo Ma, Meiling Zhou et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuo Ma United States 28 1.2k 909 898 762 733 160 3.2k
Luigi Del Vecchio Italy 36 2.3k 1.9× 671 0.7× 454 0.5× 828 1.1× 983 1.3× 173 4.6k
Isidro Sánchez‐García Spain 36 2.7k 2.2× 465 0.5× 381 0.4× 1.3k 1.8× 461 0.6× 115 4.4k
Yoshinobu Matsuo Japan 33 1.7k 1.4× 454 0.5× 501 0.6× 940 1.2× 1.0k 1.4× 126 3.7k
John D. Hooper Australia 35 1.9k 1.6× 817 0.9× 189 0.2× 1.1k 1.4× 406 0.6× 120 4.1k
Xiaosheng Wu United States 29 1.5k 1.3× 251 0.3× 301 0.3× 574 0.8× 683 0.9× 81 2.7k
Cornelius Miething Germany 28 3.0k 2.5× 519 0.6× 435 0.5× 1.5k 2.0× 1.2k 1.6× 68 5.1k
Robert C. Rickert United States 40 2.6k 2.2× 623 0.7× 482 0.5× 1.2k 1.5× 3.8k 5.1× 81 6.4k
Rossana Trotta United States 31 1.7k 1.4× 589 0.6× 272 0.3× 809 1.1× 1.7k 2.3× 58 3.9k
Frank Grünebach Germany 38 1.8k 1.5× 471 0.5× 276 0.3× 1.3k 1.6× 2.4k 3.3× 73 4.2k
William Damsky United States 32 1.9k 1.5× 177 0.2× 536 0.6× 1.6k 2.1× 1.4k 2.0× 122 4.7k

Countries citing papers authored by Shuo Ma

Since Specialization
Citations

This map shows the geographic impact of Shuo Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuo Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuo Ma more than expected).

Fields of papers citing papers by Shuo Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuo Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuo Ma. The network helps show where Shuo Ma may publish in the future.

Co-authorship network of co-authors of Shuo Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Shuo Ma. A scholar is included among the top collaborators of Shuo Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuo Ma. Shuo Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Jiayi, et al.. (2025). Circular RNA circAHSA1 serves as a stable serum biomarker for the diagnosis and progression of gastric cancer. Translational Oncology. 63. 102620–102620.
2.
3.
Ma, Shuo, et al.. (2024). Prognostic value and potential function of a novel heme-related LncRNAs signature in gastric cancer. Cellular Signalling. 118. 111152–111152. 1 indexed citations
4.
Ma, Shuo, Yanhua Xu, Mei Tao, et al.. (2024). RUNX1, FUS, and ELAVL1-induced circPTPN22 promote gastric cancer cell proliferation, migration, and invasion through miR-6788-5p/PAK1 axis-mediated autophagy. Cellular & Molecular Biology Letters. 29(1). 9 indexed citations
5.
Chen, Yaya, Yuming Yao, Shuo Ma, et al.. (2024). Detection of HBV pgRNA by catalytic hairpin assembly combined with two Kinds of immunochromatographic strips. Microchemical Journal. 207. 112075–112075. 1 indexed citations
6.
Ma, Shuo, Shunming Liu, Yu Huang, et al.. (2024). Shared whole environmental etiology between Alzheimer’s disease and age-related macular degeneration. PubMed. 10(1). 36–36. 2 indexed citations
7.
8.
Lin, Adam Yuh, Jonathan Moreira, Kenneth R. Carson, et al.. (2024). CT-630 No Impact of Prophylactic Corticosteroid Use in Patients Receiving Axicabtagene Ciloleucel for Large B-Cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 24. S611–S612.
9.
10.
Zhou, Meiling, Yuming Yao, Shuo Ma, et al.. (2023). Dual-targeted and dual-sensitive self-assembled protein nanocarrier delivering hVEGI-192 for triple-negative breast cancer. International Journal of Biological Macromolecules. 245. 125475–125475. 6 indexed citations
11.
12.
Yang, Qian, Shan Kong, Yanhua Xu, et al.. (2023). MicroRNA miR-1275 coordinately regulates AEA/LPA signals via targeting FAAH in lipid metabolism reprogramming of gastric cancer. Cell Death and Disease. 14(1). 62–62. 12 indexed citations
13.
Karmali, Reem, Jeremy S. Abramson, Deborah M. Stephens, et al.. (2023). Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphoma. Blood Advances. 7(23). 7361–7368. 3 indexed citations
14.
Wang, Michael, Nirav N. Shah, Wojciech Jurczak, et al.. (2023). MCL-155 Pirtobrutinib in Covalent BTK Inhibitor Pre-Treated Mantle Cell Lymphoma: Updated Results and Subgroup Analysis from the Phase 1/2 BRUIN Study With >3 Years Follow-Up from Start of Enrollment. Clinical Lymphoma Myeloma & Leukemia. 23. S459–S459. 1 indexed citations
15.
Yang, Zhi, Chunming Xu, Shuo Ma, et al.. (2022). Effects of betaine supplementation on reproductive performance of breeding geese. British Poultry Science. 64(2). 283–288. 1 indexed citations
16.
Trotman, Judith, Christian Buske, Alessandra Tedeschi, et al.. (2021). Single-Agent Ibrutinib for Rituximab-Refractory Waldenström Macroglobulinemia: Final Analysis of the Substudy of the Phase III InnovateTM Trial. Clinical Cancer Research. 27(21). 5793–5800. 27 indexed citations
17.
18.
Ma, Shuo, Xinchun Li, Xinyue Wang, et al.. (2019). Current Progress in CAR-T Cell Therapy for Solid Tumors. PMC. 2 indexed citations
19.
Sun, Yuqiang, Xiaodong Luo, Kang Yang, et al.. (2015). Neural overexpression of multidrug resistance-associated protein 1 and refractory epilepsy: a meta-analysis of nine studies. International Journal of Neuroscience. 126(4). 308–317. 16 indexed citations
20.
Liu, Yuan, Sunil K. Shaw, Shuo Ma, et al.. (2004). Regulation of Leukocyte Transmigration: Cell Surface Interactions and Signaling Events. The Journal of Immunology. 172(1). 7–13. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luigi Del Vecchio Breakdown of academic impact, for papers by Isidro Sánchez‐García Breakdown of academic impact, for papers by Yoshinobu Matsuo Breakdown of academic impact, for papers by John D. Hooper Breakdown of academic impact, for papers by Xiaosheng Wu Breakdown of academic impact, for papers by Cornelius Miething Breakdown of academic impact, for papers by Robert C. Rickert Breakdown of academic impact, for papers by Rossana Trotta Breakdown of academic impact, for papers by Frank Grünebach Breakdown of academic impact, for papers by William Damsky
Rankless by CCL
2026